Package 68788-6447-3

{"route": ["ORAL"], "spl_id": "31a7329b-a246-4638-b436-6d3bb337c582", "openfda": {"nui": ["N0000175596", "N0000175375", "M0543661"], "unii": ["Q8X02027X3"], "rxcui": ["310459"], "spl_set_id": ["196f706b-7234-4c53-ada2-93c4df02f178"], "pharm_class_cs": ["Fibric Acids [CS]"], "pharm_class_epc": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]"], "pharm_class_moa": ["Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-6447-3)", "package_ndc": "68788-6447-3", "marketing_start_date": "20160802"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-6447-6)", "package_ndc": "68788-6447-6", "marketing_start_date": "20160802"}], "brand_name": "Gemfibrozil", "product_id": "68788-6447_31a7329b-a246-4638-b436-6d3bb337c582", "dosage_form": "TABLET", "pharm_class": ["PPAR alpha [CS]", "Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"], "product_ndc": "68788-6447", "generic_name": "Gemfibrozil", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gemfibrozil", "active_ingredients": [{"name": "GEMFIBROZIL", "strength": "600 mg/1"}], "application_number": "ANDA077836", "marketing_category": "ANDA", "marketing_start_date": "20160802", "listing_expiration_date": "20261231"}